4//SEC Filing
Amron Arthur H 4
Accession 0001437749-21-028833
CIK 0001196298other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 9:16 PM ET
Size
7.4 KB
Accession
0001437749-21-028833
Insider Transaction Report
Form 4
NEPHROS INCNEPH
AMRON ARTHUR H
Director
Transactions
- Award
Common Stock
2021-12-14+4,582→ 4,582 total - Award
Stock Option (Right to Buy)
2021-12-14+7,062→ 7,062 totalExercise: $6.82Exp: 2031-12-14→ Common Stock (7,062 underlying)
Footnotes (2)
- [F1]On December 14, 2021, the Company granted 4,582 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.
- [F2]On December 14, 2021, the Company granted an option to purchase 7,062 shares of common stock of the Company (the "Option") in respect of the service by Mr. Amron as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.
Documents
Issuer
NEPHROS INC
CIK 0001196298
Entity typeother
Related Parties
1- filerCIK 0001179697
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 9:16 PM ET
- Size
- 7.4 KB